On September 26, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting results. Accordingly, a proposal submitted by Cable Car Capital LLC requesting the Company to remove the company?s preferred stock rights agreement was not approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5164 USD | -7.62% | -6.11% | -37.15% |
30/05 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
13/05 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.15% | 1.88Cr | |
+16.42% | 12TCr | |
+19.02% | 11TCr | |
+2.65% | 2.27TCr | |
-11.63% | 1.67TCr | |
-16.33% | 1.66TCr | |
-39.57% | 1.69TCr | |
+2.68% | 1.36TCr | |
+21.16% | 1.1TCr | |
+108.78% | 1.04TCr |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences